Liver Cancer

Gene Transfer System Specifically Targets Hepatocellular Carcinoma Cells

Published in Gene Therapy Weekly, August 9th, 2001

by Sonia Nichols, senior medical writer - A research group in Hong Kong has developed a gene delivery system that specifically targets hepatocellular carcinoma cells.

Patients stricken by liver cancers caused by viral hepatitis, liver toxins, or cirrhosis could potentially benefit from the gene transfer system, which uses a receptor-mediated delivery mechanism to transfer tumor suppressor genes directly to liver cancer cells.

"For gene therapy to be effective in cancers, it is necessary to deliver therapeutic genes into cells with high specificity and efficiency," commented Terence Kin-Wah Lee and colleagues, University of Hong Kong.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2001-08-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry